Clinical trial
Collagen Peptides and Cellular Aging: a Randomized, Placebo-controlled Intervention Study on Telomere Length, Inflammation, Body Composition, and Functional Capacity in Middle-aged and Older Adults
NCT07456449 is registered in ClinicalTrials.gov with University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collagen Peptides and Cellular Aging: a Randomized, Placebo-controlled Intervention Study on Telomere Length, Inflammation, Body Composition, and Functional Capacity in Middle-aged and Older Adults
- Lead sponsor
- University of Vienna
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 22, 2026
- Completion date
- August 31, 2028
- Enrollment
- 125 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biological ageing, healthy aging, longevity